Cancer Drug, Dasatinib, Helps Some Kids With Rare Type of Leukemia

MONDAY, June 5, 2017 -- The cancer drug dasatinib shows promise in treating children with chronic myeloid leukemia (CML) caused by the gene BCR-ABL, also known as the Philadelphia chromosome, researchers report. " Despite the fact that there is a...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news